CLINICAL_TRIALS
trial_result
· 2021-07-20
Clinical Trial Update: Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food [Phase 4]
Summary
Phase 4 trial evaluating palatability and tolerability of deferasirox when taken with various meals and liquids or crushed into food.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Transfusional Hemosiderosis | Phase 4 | Status: COMPLETED | Results posted: 2021-07-20